Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENGUIN: QLS-111 in NPDR, OAG, or NTG
NCT07354477Phase 2Completed
- Start
- Feb 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QLS-111 in open-angle glaucoma (OAG), normal tension glaucoma (NTG). Started Feb 2026; status: completed.
02
Drugs
QLS-111
03
Conditions
open-angle glaucoma (OAG)normal tension glaucoma (NTG)
Beyond the preview
Go deeper on NCT07354477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07354477.